Let's Play PET References - "K"

[Back to Menu] [Back to Index]
  • Karbe, H, Holthoff, V, Huber, M, Herholz, K, Wienhard, K, Wagner, R, Heiss, W: Positron emission tomography in degenerative disorders of the dopaminergic system. J Neural Transm, 4:121-30, 1992.

  • Karbe, H, Wienhard, K, Hamacher, K, Huber, M, et al: Positron emission tomography with (18F) methylspiperone demonstrates D2 dopamine receptor binding differences of clozapine and haloperidol. J Neural Transm, 86:163-73, 1991.

  • Keen R, Barrio J, Huang S, Hawkins R, Phelps M. In vivo cerebral protein synthesis rates with leucyl-transfer RNA used as a precursor pool: determination of biochemical parameters to structure tracer kinetic models for positron emission tomography. J Cereb Blood Flow Metab, 9:429-45, 1989.

  • Kempler, D, Metter, E, Jackson, C, Hanson, W, Riege, W, Mazziotta, J, Phelps, M: Disconnection and cerebral metabolism. The case for aphasia. Arch Neurol, 45:277-9, 1988.

  • Kern KA. [14C]deoxyglucose uptake and imaging in malignant melanoma. J Surg Res, 1991, 50:643-7.

  • Kern, KA, Brunetti, A, Norton, JA, et al: Metabolic imaging of human extremity musculoskeletal tumors by PET. J Nucl Med, 29:181-186, 1988.

  • Kerrigan, J, Chugani, H and Phelps, M: Regional cerebral glucose metabolism in clinical subtypes of cerebral palsy. Pediatric Neurol, 7:415-25, 1991.

  • Kilbourn, M, Dasilva, J, Frey, K, Koeppe, R, Kuhl, D. Invivo imaging of vesicular monoamine transporters in human brain using [C-11]Tetrabenazine and positron emission tomography. J Neurochem, 60: 2315-8, 1993.

  • Kim, CK, Alavi, JB, Alavi, A, Reivich, M: New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose. J Neurooncol, 10:85-91, 1991.

  • Kish, S, Shannak, K, Hornykiewicz, O: Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N Engl J Med, 318:876-880, 1988.

  • Kopin I. In-vivo quantitative imaging of catecholaminergic nerve terminals in brain and peripheral organs using positron emission tomography (PET). J Neural Transm Suppl, 32:19-27, 1990.

  • Kosslyn, S, Alpert, N, Thompson, W, Maljkovic, V, Weise, S, Chabris, C, Hamilton, S, Rauch, S, Buonanno, F. Visual mental imagery activates topographically organized visual cortex - PET investigations. J Cog Neurosci, 5: 263-287, 1993.

  • Krivokapich, J, Barrio, J, Huang, SC, Phelps, M and Schelbert, H: Dynamic positron tomographic imaging with nitrogen-13 glutamate in patients with coronary artery disease: comparison with nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose imaging. J Amer Coll Cardiol, 16:1158-1167, 1990.

  • Krivokapich, J, Huang, S, Ratib, O and Schelbert, H: Noninvasive detection of functionally significant coronary artery stenoses with exercise and positron emission tomography. Amer Heart J, 122:202-211, 1991.

  • Krivokapich, J, Smith, G, Huang, S, Hoffman, E, Ratib, O, Phelps, M, Schelbert, H. N-13 ammonia myocardial imaging at rest and with excercise in normal volunteers: quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation, 80:1328-37, 1989.

  • Krivokapich, J, Stevenson, L, Kobashigawa, J, Huang, SC and Schelbert, H: Quantification of absolute myocardial perfusion at rest and during exercise with positron emission tomography after human cardiac transplantation. J Amer Coll Cardiol, 18:512-517, 1991.

  • Kubota, K, Matsuzawa, T, Amemiya, A, et al., Imaging of breast cancer with [18F]fluorodeoxyglucose and positron emission tomography. J Comput Assist Tomogr, 13:1097-1098, 1989.

  • Kuhl, D, Metter, J, Benson, D, Ashford, J, Riege, W, et al: Similarities of cerebral glucose metabolism in Alzheimer's and Parkinsonian dementia. J Cereb Blood Flow Metab, 5[Suppl 1]:169-170, 1985.

  • Kuhl, D, Phelps, M, Markham, C, et al. Cerebral metabolism and atrophy in Huntington's disease determined by 18-FDG and computed tomographic scan. Ann Neurol, 12:425-34, 1982.

  • Kuhle W; Porenta G; Huang S; Buxton D; Gambhir S; Hansen H; Phelps M; Schelbert H. Quantification of regional myocardial blood flow using 13N-ammonia and reoriented dynamic positron emission tomographic imaging. Circulation, 1992, 86:1004-17.

  • Kuhle, W, Porenta, G, Huang, SC, Buxton, D, Gambhir, S, Hansen, H, et al.: Quantification of regional myocardial blood flow using N-13-ammonia and reoriented dynamic positron emission tomographic imaging. Circulation , 86:1004-1017, 1992.

  • Kuhle, W, Porenta, G, Huang, SC, Phelps, M and Schelbert, H: Issues in the quantitation of reoriented cardiac PET images. J Nucl Med, 33:1235-1242, 1992.

  • Kumar, A, et al., High resolution PET studies in Alzheimer's disease. Neuropsychopharmacology, 4:35-46, 1991.

  • Kuwert, T, Lange, H, Langen, K-J, Herzog, H, Aulich, A, Feinendegen, L: Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain, 113:1405-23, 1990.

    Let's Play PET, Copyright 1992, 1993 Regents of the University of California
    All Rights Reserved

    [Back to Menu] [Back to Index]